C WorldWide Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-18,102
| Closed | -$1.26M | – | 133 |
|
|
2018
Q3 | $1.26M | Sell |
18,102
-19,968
| -52% | -$1.38M | 0.02% | 105 |
|
|
2018
Q2 | $2.88M | Buy |
38,070
+7,141
| +23% | +$540K | 0.04% | 87 |
|
|
2018
Q1 | $1.63M | Sell |
30,929
-5,398
| -15% | -$284K | 0.03% | 87 |
|
|
2017
Q4 | $1.94M | Sell |
36,327
-27,715
| -43% | -$1.48M | 0.03% | 86 |
|
|
2017
Q3 | $3.82M | Buy |
64,042
+15,301
| +31% | +$912K | 0.05% | 75 |
|
|
2017
Q2 | $3.85M | Sell |
48,741
-16,344
| -25% | -$1.29M | 0.06% | 71 |
|
|
2017
Q1 | $5.4M | Buy |
65,085
+11,485
| +21% | +$953K | 0.09% | 51 |
|
|
2016
Q4 | $4.25M | Sell |
53,600
-29,807
| -36% | -$2.37M | 0.08% | 60 |
|
|
2016
Q3 | $5.84M | Sell |
83,407
-14,000
| -14% | -$980K | 0.1% | 46 |
|
|
2016
Q2 | $3.78M | Sell |
97,407
-101,500
| -51% | -$3.94M | 0.07% | 50 |
|
|
2016
Q1 | $8.06M | Sell |
198,907
-20,000
| -9% | -$810K | 0.16% | 41 |
|
|
2015
Q4 | $19.4M | Sell |
218,907
-55,000
| -20% | -$4.88M | 0.34% | 31 |
|
|
2015
Q3 | $20.3M | Sell |
273,907
-5,500
| -2% | -$407K | 0.34% | 29 |
|
|
2015
Q2 | $22.6M | Buy |
279,407
+145,000
| +108% | +$11.7M | 0.32% | 30 |
|
|
2015
Q1 | $5.63M | Buy |
134,407
+40,000
| +42% | +$1.68M | 0.08% | 54 |
|
|
2014
Q4 | $1.46M | Sell |
94,407
-45,593
| -33% | -$707K | 0.02% | 79 |
|
|
2014
Q3 | $1.72M | Buy |
+140,000
| New | +$1.72M | 0.03% | 81 |
|